Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDAGlobeNewsWire • 02/11/26
Biotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11thGlobeNewsWire • 02/05/26
3 Healthcare IT Stocks Up More Than 20% in 2025 With More Room to RunZacks Investment Research • 12/23/25
Biotricity Strengthens Path to Scalable Profitability with Sustained Margins & Operational Efficiency in Second Quarter Fiscal 2026GlobeNewsWire • 11/14/25
Biotricity to Host Fiscal 2026 Second Quarter Financial Results and Business Update Call on November 14thGlobeNewsWire • 11/07/25
Health-E Commerce® and Biotricity® Collaborate to Expand Remote Cardiac Monitoring with Bioheart® for Flexible Spending Account (FSA) and Health Savings Account (HSA) UsersPRNewsWire • 09/09/25
Biotricity and B-Secur Target the Consumer Wearables Market with Expansion of Next-Gen Cardiac Monitoring PlatformGlobeNewsWire • 09/03/25
Biotricity Reinforces Growth Trajectory, Kicking Off Fiscal 2026 with Strong First Quarter Results Featuring Revenue Growth, Positive EBITDA and Improved MarginsGlobeNewsWire • 08/14/25
Biotricity to Host Fiscal 2026 First Quarter Financial Results and Business Update Call on August 14thGlobeNewsWire • 08/12/25
Biotricity Delivers Strong Fiscal Year 2025 Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses, Putting Profitability within ReachGlobeNewsWire • 07/17/25
Biotricity to Host Fiscal 2025 Fourth Quarter Financial Results and Business Update Call on July 18thGlobeNewsWire • 07/15/25
Biotricity Recognized by Financial Times as One of 2025's Fastest-Growing Companies in the Americas, Growing 256.4% Over the Period AnalyzedGlobeNewsWire • 04/08/25
Biotricity Expands IP Portfolio & Strategy with 14 New Patents, Reinforcing Innovation & Leadership in Remote Monitoring, Diagnostics, & Chronic Disease ManagementGlobeNewsWire • 03/12/25
Biotricity Delivers Record Margins, Record Revenues, and Record Cashflows with 21.7% Year-Over-Year Sales Growth for its Third Quarter of Fiscal 2025GlobeNewsWire • 02/20/25
Biotricity Announces Cashflow Breakeven with Biggest Quarter in History and a Revenue Increase of 11%GlobeNewsWire • 02/17/25
Biotricity and B-Secur Partner to Launch the Most Comprehensive Device-Neutral Ambulatory Cardiac Monitoring PlatformPRNewsWire • 01/15/25